Publication:
Disease model: LAMP-2 enlightens Danon disease

dc.bibliographiccitation.firstpage37
dc.bibliographiccitation.issue1
dc.bibliographiccitation.journalTrends in Molecular Medicine
dc.bibliographiccitation.lastpage39
dc.bibliographiccitation.volume7
dc.contributor.authorSaftig, P.
dc.contributor.authorTanaka, Y.
dc.contributor.authorLullmann-Rauch, R.
dc.contributor.authorvon Figura, Kurt
dc.date.accessioned2018-11-07T09:40:13Z
dc.date.available2018-11-07T09:40:13Z
dc.date.issued2001
dc.description.abstractDanon disease ('lysosomal glycogen storage disease with normal acid maltase') is characterized by a cardiomyopathy, myopathy and variable mental retardation. Mutations in the coding sequence of the lysosomal-associated membrane protein 2 (LAMP-2) were shown to cause a LAMP-2 deficiency in patients with Danon disease. LAMP-2 deficient mice manifest a similar vacuolar cardioskeletal myopathy. In addition to the patient reports LAMP-2 deficiency in mice causes pancreatic, hepatocytic, endothelial and leucocyte vacuolation. LAMP-2 deficient mice represent a valuable animal model of Danon disease. They will further be used to study the exact role of LAMP-P in autophagy and to analyse the consequences of an impaired autophagic pathway in various tissues.
dc.identifier.doi10.1016/S1471-4914(00)01868-2
dc.identifier.isi000169932200010
dc.identifier.pmid11427988
dc.identifier.urihttps://resolver.sub.uni-goettingen.de/purl?gro-2/33461
dc.notes.statuszu prüfen
dc.notes.submitterNajko
dc.publisherElsevier Sci Ltd
dc.relation.issn1471-4914
dc.titleDisease model: LAMP-2 enlightens Danon disease
dc.typereview
dc.type.internalPublicationyes
dc.type.peerReviewedyes
dc.type.statuspublished
dspace.entity.typePublication

Files

Collections